US Stock MarketDetailed Quotes
VNDA Vanda Pharmaceuticals
- 5.150
- -0.040-0.77%
Close Nov 29 13:00 ET
- 5.290
- +0.140+2.72%
Post 17:01 ET
300.29MMarket Cap-17758P/E (TTM)
5.250High5.080Low264.86KVolume5.210Open5.190Pre Close1.36MTurnover0.50%Turnover Ratio128.75P/E (Static)58.31MShares6.75052wk High0.55P/B271.00MFloat Cap3.46052wk Low--Dividend TTM52.62MShs Float33.440Historical High--Div YieldTTM3.28%Amplitude0.450Historical Low5.142Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Vanda Pharmaceuticals Stock Forum
Vanda Pharmaceuticals Confirms Receipt of Economically Identical Unsolicited, Non-Binding Proposal from Cycle Group Holdings Ltd.
Vanda Pharmaceuticals confirmed receipt of a second unsolicited, non-binding proposal from Cycle Group Holdings to acquire the company for $8.00 per share in cash. This proposal, received on September 23, 2024, is economically identical to the previously rejected offer from May 24, 2024.
Vanda's Board of Directors unanimously dete...
Cycle Pharmaceuticals Reaffirms All-Cash Proposal to Acquire Vanda Pharmaceuticals for $8.00 Per Share
Cycle Pharmaceuticals has reaffirmed its proposal to acquire Vanda Pharmaceuticals (NASDAQ: VNDA) for $8.00 per share in an all-cash transaction. This offer represents an 80% premium to Vanda's closing share price on October 11, 2024, and values the company at $488 million on a fully diluted basis.
Cycle criticizes Vanda's board for refusing to engage and fo...
No comment yet